| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
1020 |
| issn |
0277-0008
1875-9114 |
| issueIdentifier |
8 |
| pageRange |
1020; author reply 1021-1020 |
| publicationName |
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy |
| startingPage |
1020; author reply 1021 |
| bibliographicCitation |
Hansen DB. Antithrombotic drugs for secondary stroke prophylaxis--a comment. Pharmacotherapy. 2001 Aug;21(8):1020; author reply 1021–2. doi: 10.1592/phco.21.11.1020.34522. PMID: 11718493. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b41b549102e87342aaaae6ca6f2b54cc |
| date |
200108 |
| identifier |
https://doi.org/10.1592/phco.21.11.1020.34522
https://pubmed.ncbi.nlm.nih.gov/11718493 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0277-0008
https://portal.issn.org/resource/ISSN/1875-9114
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6511 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Antithrombotic drugs for secondary stroke prophylaxis--a comment |
| discusses |
http://id.nlm.nih.gov/mesh/M0006533
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0008434
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0539734
http://id.nlm.nih.gov/mesh/M0006823
http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0001864 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D005343Q000627
http://id.nlm.nih.gov/mesh/D020521Q000517 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D004176Q000009
http://id.nlm.nih.gov/mesh/D005343Q000009
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D001241Q000009
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D000068342
http://id.nlm.nih.gov/mesh/D004176Q000627
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D010975Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004338 |